- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroendocrine Tumors in New Zealand
Total 3215 results
-
Bristol-Myers SquibbCompletedAdvanced MelanomaUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Islet Cell CarcinomaUnited States
-
VicalCompletedMetastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
AstraZenecaCompleted
-
Syneos HealthOncolys BioPharma IncUnknownMelanoma Stage Iv | Melanoma Stage IIIUnited States
-
University of New MexicoMemorial Sloan Kettering Cancer CenterCompleted
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbActive, not recruitingMelanoma (Skin)United States
-
Bristol-Myers SquibbMedarexCompleted
-
Nina BhardwajMemorial Sloan Kettering Cancer Center; NYU Langone Health; Ludwig Institute... and other collaboratorsCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States, New Zealand
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
ActelionCompleted
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, United Kingdom, Taiwan, Australia
-
NeoImmuneTechImmune Oncology NetworkTerminatedMelanoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Idera Pharmaceuticals, Inc.CompletedMelanoma | Refractory Solid TumorsUnited States, Israel
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic MelanomaUnited States
-
Nina BhardwajCancer Research Institute, New York City; Ludwig Institute for Cancer Research and other collaboratorsCompleted
-
The New York Eye Cancer CenterGenentech, Inc.CompletedRadiation Retinopathy | Choroidal MelanomaUnited States
-
Yale UniversityCompletedMelanoma | Lung CancerUnited States
-
Melanoma Institute AustraliaActive, not recruiting
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Merkel Cell Carcinoma | Stage III Merkel Cell Carcinoma AJCC v7 | Stage IV Merkel Cell Carcinoma AJCC v7 | Stage IIIA Merkel Cell Carcinoma AJCC v7 | Stage IIIB Merkel Cell Carcinoma AJCC v7United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingGastric Neuroendocrine Carcinoma | Intestinal Neuroendocrine Carcinoma | Pancreatic Neuroendocrine CarcinomaUnited States
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Legend Biotech USA IncRecruitingSmall Cell Lung Cancer Extensive Stage | Large Cell Neuroendocrine Carcinoma of the LungUnited States
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterRecruiting
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Rockefeller UniversityCompletedMelanoma | Neoplasm MetastasisUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Novartis PharmaceuticalsCompletedBRAF Positive Metastatic MelanomaUnited States
-
AmgenCompletedMelanomaUnited States, France, Germany
-
Molecular Insight Pharmaceuticals, Inc.UnknownPheochromocytoma | ParagangliomaUnited States
-
Genta IncorporatedCompletedDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaMelanoma (Skin)United States